These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19038779)

  • 1. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.
    Farnsworth SJ; Volz TJ; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2009 Mar; 328(3):807-12. PubMed ID: 19038779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors.
    Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2008 Oct; 327(1):161-7. PubMed ID: 18591219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles.
    Volz TJ; Farnsworth SJ; King JL; Riddle EL; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2007 Nov; 323(2):738-45. PubMed ID: 17693585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate-induced alterations in synaptic vesicle trafficking and activity.
    Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE
    Ann N Y Acad Sci; 2008 Oct; 1139():285-90. PubMed ID: 18991873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion increases striatal vesicular monoamine transport.
    Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1150-3. PubMed ID: 11504813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release.
    Chu PW; Hadlock GC; Vieira-Brock P; Stout K; Hanson GR; Fleckenstein AE
    J Neurochem; 2010 Oct; 115(2):325-32. PubMed ID: 20649837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles.
    Volz TJ; Farnsworth SJ; Hanson GR; Fleckenstein AE
    J Neurosci Methods; 2009 Feb; 177(1):177-82. PubMed ID: 18992277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent differences in dopamine transporter and vesicular monoamine transporter-2 function and their implications for methamphetamine neurotoxicity.
    Volz TJ; Farnsworth SJ; Rowley SD; Hanson GR; Fleckenstein AE
    Synapse; 2009 Feb; 63(2):147-51. PubMed ID: 19021208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.
    Schmitz Y; Lee CJ; Schmauss C; Gonon F; Sulzer D
    J Neurosci; 2001 Aug; 21(16):5916-24. PubMed ID: 11487614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.
    Riddle EL; Topham MK; Haycock JW; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2002 Aug; 449(1-2):71-4. PubMed ID: 12163108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.
    Truong JG; Newman AH; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2004 Nov; 504(1-2):27-32. PubMed ID: 15507217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.
    Sandoval V; Riddle EL; Hanson GR; Fleckenstein AE
    J Neurosci; 2002 Oct; 22(19):8705-10. PubMed ID: 12351745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.
    Ugarte YV; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2003 Jul; 472(3):165-71. PubMed ID: 12871750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles.
    Tucker KR; Block ER; Levitan ES
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4485-94. PubMed ID: 26216995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.
    Truong JG; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2004 May; 492(2-3):143-7. PubMed ID: 15178358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration.
    Truong JG; Rau KS; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2003 Aug; 474(2-3):223-6. PubMed ID: 12921866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.